Navigation Links
Elsevier announces new journal on inflammatory bowel diseases
Date:9/6/2007

Amsterdam, 06 September 2007 Elsevier in partnership with the European Crohns and Colitis Organisation (ECCO) is set to launch the Journal of Crohns and Colitis, a new international journal on inflammatory bowel diseases (IBD). This quarterly journal will be the official journal of the ECCO society and the first print issue will be available in September 2007.

The Journal of Crohn's and Colitis is concerned with the dissemination of knowledge on clinical, basic science and innovative methods related to inflammatory bowel diseases. The journal will publish original articles, review papers, editorials, leading articles, view points, case reports, innovative methods and letters to the editor. Supplemental issues of the journal will be published under a separate title, Journal of Crohn's and Colitis Supplements.

Miquel Gassull, M.D., Ph.D., Hospital Universitari Germans Trias I Pujol in Badalona, Spain and president of ECCO, will serve as the Editor-in-Chief of the new journal. The Editor-in-Chief is joined by a group of prestigious associate editors including Yehuda Chowers, Jean-Frd ric Colombel, Daan Hommes, Jack Satsangi, Stefan Schreiber, Sverine Vermeire and the consensus and guidelines editors Eduard Stange and Simon Travis.

Although it is the official journal of ECCO, the Journal of Crohn?s and Colitis is open to everyone in the world interested and working in the field of inflammatory bowel diseases commented Miquel Gassull. This will become a high quality journal, opening an interactive pathway between clinicians and basic scientists, publishing the best reviews, clinical trials, good observational data, modern epidemiology and relevant breaking news on the diagnosis and therapy of IBD.


'/>"/>

Contact: Koos Admiraal
k.admiraal@elsevier.com
31-204-853-747
Elsevier
Source:Eurekalert

Page: 1

Related medicine news :

1. Partnership Between Diabetes India And Elsevier Announced
2. PM announces a new health care order for India
3. PowderMed Announces Needle-Less Flu Vaccine
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B ... York City on October 11, 2017. , The annual award competition recognizes editorial and ...
(Date:10/12/2017)... ... ... On Saturday, October 21, the Health & Wellness Center at Florida Hospital ... for the American Heart Association Heart Walk. Teams of up to 10 people can ... their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on Saturday, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief ... advancements to physician colleagues, skilled nursing facility medical directors and other clinicians at ... of Wound Care." , "At many of these conferences we get to educate ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: